Epivir Hbv (Lamivudine)

Epivir HBV (Lamivudine) – Patient Information Guide

Basic Product Information

Mechanism of Action

• For Patients: Epivir HBV (Lamivudine) works by stopping the hepatitis B virus (HBV) from multiplying in your body. This helps reduce liver damage caused by the virus and supports your overall liver health.
• For Specialists: Lamivudine is a synthetic nucleoside analogue. It is phosphorylated intracellularly to its active triphosphate form, which inhibits HBV DNA polymerase by causing chain termination during viral DNA replication. It selectively targets HBV, with demonstrated good tolerability and a relatively low barrier for resistance over time.

Pharmacokinetics

• Absorption: Rapidly absorbed after oral administration, with peak plasma concentrations typically within 1 hour.
• Bioavailability: Over 80%.
• Metabolism: Limited hepatic metabolism, mainly excreted unchanged in the urine.
• Elimination Half-Life: About 5-7 hours.
• Duration of Action: Requires daily dosing for ongoing effect.
• Special Groups: Slower renal clearance in the elderly or those with kidney impairment may require dose adjustments.

Use in Everyday Life and Best Practices

Lamivudine is primarily used to treat chronic hepatitis B infection. In Australia, it is available in tablet and oral solution form, allowing flexibility for adults and children. Lamivudine is also a key medicine in HIV treatments (as part of combination therapy), but forms and dosing differ—always confirm with your prescriber.

• Typical Dose for Hepatitis B (Adults): 100 mg once daily (tablet or equivalent liquid form)
• For Children: The dose is based on body weight or surface area; paediatric dosing should be supervised by a specialist.
• Take at the same time each day to maintain steady levels in your body.
• Do not stop taking Epivir HBV suddenly unless directed—sudden discontinuation can cause serious liver complications.
• Do not share your medicine, even if someone has similar symptoms.

Dosing in the Morning vs Evening

• Morning: May fit easily into a daily routine alongside breakfast; helps avoid missed doses.
• Evening: May be preferred if patients take multiple medications in the evening.
• Key Point: The most important factor is daily consistency—take at the same time every day.
• Tips: Set daily alarms or link dosing to a regular activity (e.g., morning tea or brushing teeth).

Taking with Food or on an Empty Stomach

• Lamivudine can be taken with or without food in Australia. Food has minimal effect on absorption.
• You may wish to take with food if you experience stomach irritation.
• Common English breakfast options—such as toast, cereal, or fruit—are compatible with Lamivudine dosing routines.
• Drinking water is preferred.

Interaction Warnings

Indications

Dosing According to Clinical Indications

Safety Profile & Side Effects

• Common Side Effects:
  • Headache
  • Tiredness or fatigue
  • Cough or sore throat
  • Nausea, diarrhoea, abdominal pain
  • Fever or chills (rare)
• Rare but Serious Side Effects:
  • Severe liver inflammation (hepatitis flare) if stopped suddenly
  • Lactic acidosis (very uncommon, but serious – symptoms include muscle pain, trouble breathing, or stomach pain)
  • Pancreatitis (particularly in children – seek urgent medical attention for severe stomach pain)
• Warnings:
  • Do not use if allergic to lamivudine or any ingredient in the product.
  • Discuss with your doctor if pregnant, breastfeeding, or planning pregnancy.
  • Requires regular liver and kidney function monitoring during long-term use.

Guidelines for Proper Use (Practical Pharmacy Advice in Australia)

1. Always take Lamivudine exactly as prescribed by your specialist or GP.
2. Keep track of your dosing schedule—missed doses decrease effectiveness and risk liver flare.
3. Arrange regular blood tests to monitor your liver function and viral load.
4. Inform your healthcare provider of any other medicines, herbal remedies, or supplements you are taking.
5. Do not share your medicine with anyone else.
6. Store tablets in a cool, dry place (below 25°C) and away from sunlight.
7. Pack your medicine safely when travelling within Australia.
8. Order prescription repeats in a timely manner from your pharmacist.
9. Report any yellowing of the skin or eyes, severe abdominal pain, or unusual tiredness to your doctor immediately.

Alternative Treatment Options

Other antiviral options for hepatitis B management in Australia include:

• Tenofovir disoproxil fumarate (Viread): Often first-line for chronic hepatitis B; stronger resistance profile, daily oral dosing. May impact kidney function—requires monitoring.
• Entecavir (Baraclude): Effective, low resistance risk; safe for long-term use.
• Tenofovir alafenamide (Vemlidy): Similar to tenofovir disoproxil but lower impact on kidneys and bones. Not PBS-reimbursed for all patients; check eligibility.
• Interferons (PEG-IFN): Injectable options; can induce permanent viral suppression, but with more side effects and limited use, mostly in selected patients.

Comparison:
Lamivudine is well-tolerated and easy to use, but viral resistance can develop with long-term use—so specialists may recommend tenofovir or entecavir instead, especially for long-term management.

Legal, Registration, and Reimbursement Status in Australia

• Regulatory Status: Approved by Therapeutic Goods Administration (TGA) for hepatitis B treatment.
• Legal Category: Prescription only (S4).
• Reimbursement: Listed on the PBS (Pharmaceutical Benefits Scheme) for chronic hepatitis B when prescribed by a registered medical practitioner. Restrictions may apply depending on patient status and test results.
• Repeat Prescriptions: Usually available in 28-tablet packs, with authority scripts for longer-term treatment.

Latest Research and Clinical Guidance (2022–2025)

• The Australian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) 2022–2024 guidelines recommend tenofovir or entecavir as first-line therapy, but lamivudine may be suitable in certain cases (children, intolerance to others, pregnancy planning, financial/insurance constraints).
• Recent clinical data (HBV Guidelines 2023, EASL 2022 update) confirm lamivudine’s safety and efficacy, but highlight increased rates of viral resistance after 1-2 years of therapy, especially in adults.
• Combination HBV-HIV treatments always require specialist input.
• All patients require regular viral load and liver function monitoring (3–6 monthly), as abrupt discontinuation can be dangerous.
• For updated hepatitis B management guidance, reference: ASHM Hepatitis B resources.

Availability and Delivery Information

Frequently Asked Questions (FAQ)

1. Can I drink alcohol while taking Epivir HBV?
   Answer: Occasional, moderate alcohol intake is not strictly prohibited, but it is best to limit alcohol as it can put additional strain on your liver. Heavy drinking is strongly discouraged.
2. What should I do if I forget to take a dose?
   Answer: Take it as soon as you remember. If it’s nearly time for your next dose, skip the missed one—do not double up. Maintain your regular schedule moving forward.
3. Can Epivir HBV cure hepatitis B?
   Answer: Lamivudine is not a cure, but it effectively controls the virus and reduces the risk of liver damage while you are taking it.
4. Is lamivudine safe in pregnancy?
   Answer: Lamivudine may be safe in pregnancy under specialist supervision. Always inform your doctor if you are pregnant or planning pregnancy; other medicines may be preferred.
5. Can I stop treatment if my viral load becomes undetectable?
   Answer: Never stop or adjust the dose without your doctor’s advice. Stopping suddenly can be dangerous.

For more information, or if you have questions about your medicine, talk to your doctor, pharmacist, or hepatitis B specialist nurse. You can also contact the Hepatitis Australia website for further resources and support.